NCT03478293View on ClinicalTrials.gov

iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications

NATerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

February 27, 2018

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions
Primary Open Angle Glaucoma (POAG)
Interventions
DEVICE

iStent inject surgery

Micro-invasive glaucoma surgery (MIGS) to implant iStent inject

Trial Locations (1)

04023-62

Department of Ophthalmology - UNIFESP/ Hospital São Paulo, São Paulo

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY

NCT03478293 - iStent Inject in OAG Subjects on 2 Pre-op Topical Ocular Hypotensive Medications | Biotech Hunter | Biotech Hunter